To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Talaris Therapeutics goes public
Boston-based Talaris Therapeutics Inc, a cell therapy company, has raised about $150 million for its IPO after pricing its over 8.8 million shares at $17 per share.
